World's Largest QEEG Database
Leverage the power of big data with our comprehensive, sex-classified normative database. Compare patient data against a robust standard for accurate assessment.
- •Extensive Coverage: Data from over 1,300 healthy individuals spanning ages 4 to 82.
- •Sex-Classified: Distinct normative data for males and females ensures higher precision in deviation analysis.
- •Advanced Mapping: Interactive 2D and 3D brain maps visualize deviations clearly and effectively.
- •Cloud Accessibility: Access analysis from anywhere via our secure cloud platform.
AI Denoising & Advanced Analytics
Our proprietary AI algorithms clean and analyze EEG data with unprecedented accuracy, providing deep insights into brain connectivity and function.
- •Auto-Denoising: Deep learning algorithms automatically identify and remove artifacts for cleaner signals.
- •AMICA Analysis: Utilizes Adaptive Mixture Independent Component Analysis for superior source separation.
- •sLORETA Imaging: Standardized Low Resolution Brain Electromagnetic Tomography for precise source localization.
- •Connectivity: Detailed ROI (Region of Interest) connectivity visualizations to understand functional networks.
Tailored for Every Need
iSyncBrain is available in three distinct series designed for specific use cases in medicine, clinical practice, and research.
M Series
Medical grade analysis suite designed for hospitals and medical centers.
Clinical Series
Optimized for private practices, therapists, and wellness centers.
Research Series
Advanced tools for academic institutions and research laboratories.
See the Results
Explore our comprehensive reports or schedule a demonstration to see the platform in action.
Research & Evidence
Read the white papers and clinical studies validating our algorithms.
View ResearchReady to upgrade your analysis?
Join hundreds of clinicians using iSyncBrain for superior patient insights.
Regulatory Disclaimer
iSyncBrain is an EEG analysis software intended for use by qualified professionals.
Important Notice regarding the M Series: The aMCI (amnestic Mild Cognitive Impairment) classifier feature included in the M Series has NOT been cleared or approved by the U.S. Food and Drug Administration (FDA). It is not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of any disease or medical condition in the United States.
All interpretations of data and reports generated by iSyncBrain should be made by a qualified healthcare professional in conjunction with other clinical information.